OR WAIT null SECS
© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
October 11, 2021
Inserts replace steroid eyedrops.
September 08, 2021
The lot contains kits with the incorrect solution for diluting vancomycin, which could lead to doses above or below recommended levels.
September 02, 2021
The product is considered “super potent” with a higher dose that could result in serious cardiac toxicities.
August 27, 2021
Tecentriq did not meet the primary end point in a postmarketing study as a first-line treatment.
August 26, 2021
Tibsovo is the first targeted therapy for IDH1-mutated cholangiocarcinoma, a cancer of the bile ducts within and outside the liver.
Developed by Ascendis Pharma, this is the first therapy that delivers growth hormone over one week.